Experimental Drug Derived From Snake Venom Shows Promise In Reversing Effects Of Stroke

NASHVILLE, Feb. 4 -- A stroke therapy derived from snake venom? According to researchers, it's not a snake oil story, but instead a possible new way to help people recover from the devastating effects of stroke.

Scientists announced the results of a 500-person trial examining the effects of an experimental stroke drug called ANCROD here today at the 24th American Heart Association International Conference on Stroke and Cerebral Circulation.

Researchers found that 42 percent of stroke victims treated with ANCROD within three hours of stroke onset had recovered the physical and mental abilities that they had prior to the stroke.

In comparison, 34 percent of those receiving an inert substance, or placebo, regained their previous faculties. However, stroke patients who received ANCROD were also at a higher risk of bleeding in the brain (5 percent of patients) when compared to those who received the placebo (2 percent).

ANCROD is not yet approved by the Food and Drug Administration for stroke treatment. Tissue plasminogen activator (TPA) is the only FDA-approved acute stroke treatment.

ANCROD is derived from the venom of a pit viper snake. Researchers discovered that in people who were bitten by the snake, blood failed to clot. Based on that observation, the venom was utilized as an anticoagulant, helping blood flow more freely through vessels.

"Like clot-dissolving drugs TPA and urokinase, the goal was for ANCROD to be administered within three hours of stroke onset," says the study's lead author, David Sherman, M.D. "Also, none of these three drugs are for use in patients who have hemorrhagic strokes, caused by a burst or leaking blood vessel in the brain."

There are sharp contrasts between the treatments, however, says Sherman.

TPA is administered in a single-dose, hour-long injection and results can be seen soon thereafter. ANCROD is given intravenously through

Contact: Brian Henry or Cathy Yarbrough
American Heart Association

Page: 1 2 3

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental hantavirus vaccine elicits strong antibody response in primates
7. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental Biology 2003 meets in San Diego April 11-15
10. Experimental gene switch increases lifespan with no ill effects
11. Experimental therapy stops allergic reactions in mice

Post Your Comments:

(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now offering its ... of 2019. The code to use during checkout is FIFTYOFF and applies to both ... nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures performed nationwide. ...
(Date:11/5/2019)... ... 05, 2019 , ... Catalent, the leading global provider of ... consumer health products, today announced it will present at the upcoming World Orphan ... – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, ...
(Date:10/30/2019)... CUMBERLAND FORESIDE, Maine (PRWEB) , ... October 29, ... ... UC4 linearity and calibration verification kits, for SIEMENS ATELLICA® analyzers, Order Numbers 701sa ... GLU, K, MG, NA, PHOS, UA, UTP, and UUN. , Each VALIDATE® kit, ...
Breaking Biology News(10 mins):
(Date:11/19/2019)... ... November 19, 2019 , ... Supercomputing Conference – Cirrascale ... for Autonomous Vehicle , Medical Imaging, and Natural Language Processing (NLP) workflows, ... Graphcore Poplar® software stack as part of its bare-metal cloud service offerings. In ...
(Date:11/12/2019)... ... 12, 2019 , ... Fiberstar, Inc., a global market leader ... a new innovative website. , After extensive research, Fiberstar revamped the ... updated ingredient usage tables by food application and video tutorials. And, this site ...
(Date:11/9/2019)... BOSTON (PRWEB) , ... November ... ... provider of artificial intelligence (AI)-powered technology for use in pathology research, today ... in liver biopsy samples from patients enrolled in the phase 3 selonsertib ...
(Date:11/5/2019)... N.J. (PRWEB) , ... November ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... its next-generation cell line development technology, GPEx® Boost. The technology enhances Catalent’s ...
Breaking Biology Technology:
Cached News: